Identifying Nosocomial Influenza A: Whole-Genome vs Hemagglutinin/Neuraminidase Sequencing
Whole-genome sequencing was better at identifying nosocomial influenza A outbreak clusters than hemagglutinin (HA)/neuraminidase (NA) gene sequencing.
Influenza
TransFLUas Study: Asymptomatic Influenza Transmission in Acute Health Care
A significant number of asymptomatic people shed the influenza virus.
First Clinical Development Candidate of Cidara’s Influenza Program Announced
Data supporting the selection of the antiviral conjugate CB-012 as Cidara Therapeutics Incorporated’s first clinical development candidate from the company’s influenza program.
Twelve Percent of Caregivers Have Pediatric Flu Vaccine Hesitancy
Most hold inaccurate beliefs about flu, flu shots, including believing child will be protected with one shot
October May Be Best Time for Older Adults to Receive Flu Shot
October may be the best time for elderly patients to receive influenza vaccinations.
Efficacy of Quadrivalent Inactivated Influenza Vaccine in Young Children
In children aged 6–35 months, vaccination with 2 doses of IIV4 can protect against influenza and reduces the frequency of severe outcomes.
AAP: Nasal Spray Vaccine Against Flu Acceptable in 2019 to 2020
Based on current data, AAP Board of Directors says either injection or nasal spray vaccination OK
CDC: Flu Season May Have Peaked
Milder strain of flu has been most common cause of cases this flu season
Antibody Response to Egg- and Cell-Grown Influenza A
Adults who received the flu vaccine in 2017 to 2018 had higher antibody titers against the egg-adapted vaccine and lower titers against circulating virus.
Oseltamivir Effective in Critically Ill Patients With Influenza A/H3N2
Oseltamivir should be administered to treat critically ill individuals with influenza, particularly when A/H3N2 is circulating.
Next post in Influenza
